Provided by Tiger Fintech (Singapore) Pte. Ltd.

ABBISKO-B

18.030
+1.1306.69%
Volume:6.07M
Turnover:108.06M
Market Cap:12.12B
PE:369.64
High:18.100
Open:16.900
Low:16.900
Close:16.900
52wk High:18.100
52wk Low:2.850
Shares:672.00M
HK Float Shares:672.00M
Volume Ratio:1.25
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.049
ROE:6.88%
ROA:2.27%
PB:4.99
PE(LYR):369.63
PS:17.92

Loading ...

Hong Kong Stock Alert | ABBISKO-B (02256) Surges Over 6% to New High as Company Continues Share Buybacks and Gains Foreign Institutional Support, Steadily Advancing Pimasertib Registration

Stock News
·
Yesterday

ABBISKO-B (02256) Subscribes to $10 Million USD Redeemable Zero-Coupon Notes

Stock News
·
Aug 28

BRIEF-Abbisko Cayman Subscribes $10 Mln In Callable Zero Coupon Notes

Reuters
·
Aug 28

Abbisko Cayman Ltd. Expands Global Reach with New Innovative Medicine Initiatives

Reuters
·
Aug 28

Abbisko Cayman Ltd - Subscribes USD10 Mln in Callable Zero Coupon Notes

THOMSON REUTERS
·
Aug 28

ABBISKO-B (02256) Repurchased 100,000 Shares for Approximately HK$1.59 Million on August 28

Stock News
·
Aug 28

Abbisko Cayman Ltd. Files Next Day Disclosure Return to HKEX, Announces Repurchase of 100,000 Shares at HKD 1,593,690

Reuters
·
Aug 28

ABBISKO-B (02256) Repurchases 200,000 Shares for HK$3.2012 Million on August 27

Stock News
·
Aug 27

Abbisko Units Gets China Clearance for Lung Cancer Drug Application; Shares Jump 3%

MT Newswires Live
·
Aug 21

BRIEF-Abbisko Cayman Says CDE Of NMPA Clears Ind For Abbisko's Pd-L1 Inhibitor Combo For NSCLC

Reuters
·
Aug 20

ABBISKO-B (02256): IND Application for Combination Therapy of Oral PD-L1 Inhibitor ABSK043 and Shanghai Allist's KRAS G12C Inhibitor for NSCLC Treatment Receives CDE Approval

Stock News
·
Aug 20

Abbisko Cayman Ltd - Cde of Nmpa Clears Ind for Abbisko's Pd-L1 Inhibitor Combo for Nsclc

THOMSON REUTERS
·
Aug 20

ABBISKO-B (02256) Repurchases 100,000 Shares for HK$1.61 Million on August 20

Stock News
·
Aug 20

HK Movers | HK's Biotech Shares Soar. CANbridge up 29%; Ab&B Bio-Tech up 26%; Abbisko up 7%

Tiger Newspress
·
Aug 13

Exploring 3 Undervalued Small Caps In Global With Insider Activity

Simply Wall St.
·
Aug 12

Abbisko's H1 Profit, Revenue Rise

MT Newswires Live
·
Aug 05

Stock Track | ABBISKO-B Soars 5.26% Following Strong H1 2025 Financial Results

Stock Track
·
Aug 05

BRIEF-Abbisko Cayman Posts H1 Revenue RMB 657.1 Million

Reuters
·
Aug 05

Abbisko Cayman H1 Net Income RMB 328.5 Million

THOMSON REUTERS
·
Aug 04

Abbisko Unit Doses First Patient in Phase 1 Trial of ABSK131

MT Newswires Live
·
Jul 23